Ikeda M - Search Results

1

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.

Oh DY, Ruth He A, Qin S, Chen LT, Okusaka T, Vogel A, Kim JW, Suksombooncharoen T, Ah Lee M, Kitano M, Burris H, Bouattour M, Tanasanvimon S, McNamara MG, Zaucha R, Avallone A, Tan B, Cundom J, Lee CK, Takahashi H, Ikeda M, Chen JS, Wang J, Makowsky M, Rokutanda N, He P, Kurland JF, Cohen G, Valle JW. Oh DY, et al. Among authors: ikeda m. NEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1. NEJM Evid. 2022. PMID: 38319896

2

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.

Ueno H, Okada S, Okusaka T, Ikeda M, Kuriyama H. Ueno H, et al. Among authors: ikeda m. Cancer Chemother Pharmacol. 2002 Feb;49(2):155-60. doi: 10.1007/s00280-001-0400-8. Epub 2001 Nov 28. Cancer Chemother Pharmacol. 2002. PMID: 11862430 Clinical Trial.

3

Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.

Ueno H, Okada S, Okusaka T, Ikeda M, Kuriyama H. Ueno H, et al. Among authors: ikeda m. Oncology. 2002;62(3):223-7. doi: 10.1159/000059569. Oncology. 2002. PMID: 12065869 Clinical Trial.

4

Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma.

Okusaka T, Okada S, Ueno H, Ikeda M, Iwata R, Furukawa H, Takayasu K, Moriyama N, Sato T, Sato K. Okusaka T, et al. Among authors: ikeda m. Oncology. 2002;62(3):228-33. doi: 10.1159/000059570. Oncology. 2002. PMID: 12065870 Clinical Trial.

5

Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection.

Kuriyama H, Okada S, Okusaka T, Ueno H, Ikeda M. Kuriyama H, et al. Among authors: ikeda m. J Gastroenterol Hepatol. 2002 Nov;17(11):1205-10. doi: 10.1046/j.1440-1746.2002.02807.x. J Gastroenterol Hepatol. 2002. PMID: 12453281

6

Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Ikeda M, Okada S, Yamamoto S, Sato T, Ueno H, Okusaka T, Kuriyama H, Takayasu K, Furukawa H, Iwata R. Ikeda M, et al. Jpn J Clin Oncol. 2002 Nov;32(11):455-60. doi: 10.1093/jjco/hyf097. Jpn J Clin Oncol. 2002. PMID: 12499417

7

Small-field radiotherapy in combination with concomitant chemotherapy for locally advanced pancreatic carcinoma.

Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, Ikeda M, Okusaka T, Ueno H, Okada S. Tokuuye K, et al. Among authors: ikeda h, ikeda m. Radiother Oncol. 2003 Jun;67(3):327-30. doi: 10.1016/s0167-8140(03)00118-x. Radiother Oncol. 2003. PMID: 12865182

8

Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.

Ueno H, Okusaka T, Ikeda M, Tokuuye K. Ueno H, et al. Among authors: ikeda m. Oncology. 2004;67(3-4):215-21. doi: 10.1159/000081320. Oncology. 2004. PMID: 15557781 Clinical Trial.

9

[Chemotherapy for hepatocellular carcinoma].

Okusaka T, Ueno H, Ikeda M. Okusaka T, et al. Among authors: ikeda m. Gan To Kagaku Ryoho. 2004 Dec;31(13):2122-8. Gan To Kagaku Ryoho. 2004. PMID: 15628756 Review. Japanese.

10

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.

Ikeda M, Okusaka T, Ueno H, Takezako Y, Morizane C. Ikeda M, et al. Cancer. 2005 Feb 15;103(4):756-62. doi: 10.1002/cncr.20841. Cancer. 2005. PMID: 15637692 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,521 results

Search Page